Bioxyne Ltd: BXN Signs Collaboration Agreement with Cy Biopharma AG
Bioxyne Ltd: Shares Out of Escrow
Bioxyne Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Bioxyne Ltd: Cleansing Notice
Bioxyne Ltd: Application for quotation of securities - BXN
Bioxyne Ltd: Proposed issue of securities - BXN
Bioxyne Ltd: Bioxyne Receives Firm Commitments to Raise $1.45 Million
Bioxyne Ltd: Bioxyne to Host Webinar on 28 March 2024
Bioxyne Ltd: Investor Presentation
Bioxyne Ltd: Notification regarding unquoted securities - BXN
Bioxyne Ltd: Notification of cessation of securities - BXN
Bioxyne Ltd: Half Yearly Report and Accounts
Bioxyne Ltd: BXN Awarded GMP Manufacturing License for Medical Cannabis
Bioxyne Ltd: Quarterly Report Listing Rule 4.7C.3
Bioxyne Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Bioxyne Ltd: Final Director's Interest Notice
Bioxyne Ltd: Retirement of Director
Bioxyne Ltd: Results of Meeting
Bioxyne Ltd: Annual General Meeting Presentation
Bioxyne Ltd: Change in substantial holding
No Data